Behavioral health comorbidities in hospital outcomes post-lower extremity amputation in patients with type 1 and type 2 diabetes.
Schmittling KA.
J Diabetes Complications. 2025 Feb;39(2):108949. doi: 10.1016/j.jdiacomp.2025.108949. Epub 2025 Jan 9.
Fasting serum copeptin and asymptomatic peripheral artery disease: No association in patients with type 1 diabetes mellitus.
Nattero-Chávez L, Martínez-García MÁ, Fernández-Durán E, Redondo López S, Dorado Avendaño B, Escobar-Morreale HF, Luque-Ramírez M.
Diabetes Metab. 2021 May;47(3):101207. doi: 10.1016/j.diabet.2020.10.005. Epub 2020 Nov 4.
Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes.
Darling JD, Bodewes TCF, Deery SE, Guzman RJ, Wyers MC, Hamdan AD, Verhagen HJ, Schermerhorn ML.
J Vasc Surg. 2018 Apr;67(4):1159-1169. doi: 10.1016/j.jvs.2017.06.119. Epub 2017 Sep 22.
Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study.
Harjutsalo V, Pongrac Barlovic D, Groop PH.
Lancet Diabetes Endocrinol. 2021 Sep;9(9):575-585. doi: 10.1016/S2213-8587(21)00172-8. Epub 2021 Jul 22.
Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.
Stabley JN, Towler DA.
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):205-217. doi: 10.1161/ATVBAHA.116.306258. Epub 2016 Dec 22.
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
Sykora D, Firth C, Girardo M, Tseng A, Wennberg P, Liedl D, Shamoun F.
Vasa. 2023 Sep;52(5):310-316. doi: 10.1024/0301-1526/a001086. Epub 2023 Jul 31.
Safety and efficacy of mild compression (18-25 mm Hg) therapy in patients with diabetes and lower extremity edema.
Wu SC, Crews RT, Najafi B, Slone-Rivera N, Minder JL, Andersen CA.
J Diabetes Sci Technol. 2012 May 1;6(3):641-7. doi: 10.1177/193229681200600319.
Low-normal free thyroxine is associated with a higher prevalence of lower extremity arterial disease in euthyroid type 2 diabetes mellitus.
Zhang M, Luo C, Wang J, Wang J, Ruan B, Hou P, Chen P.
Sci Rep. 2025 Dec 9;16(1):1709. doi: 10.1038/s41598-025-31396-1.
Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
Rautio A, Boman K, Eriksson JW, Svensson MK.
Diab Vasc Dis Res. 2016 May;13(3):183-91. doi: 10.1177/1479164115618516. Epub 2016 Jan 27.
Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers.
Zammit MC, Fiorentino L, Cassar K, Azzopardi LM, LaFerla G.
Int J Low Extrem Wounds. 2011 Sep;10(3):130-7. doi: 10.1177/1534734611418571. Epub 2011 Aug 19.
